 | • レポートコード：QFJ1-4741 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、嚢炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、プロバイオティクス、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・嚢炎治療の市場動向 ・企業の競争状況、市場シェア ・嚢炎治療の種類別市場規模と予測2016-2027（抗生物質、プロバイオティクス、その他） ・嚢炎治療の用途別市場規模と予測2016-2027（病院、専門クリニック、その他） ・嚢炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・嚢炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・嚢炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・嚢炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・嚢炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Tillotts Pharma AG、AstraZeneca、Teva Pharmaceutical Industries Ltd、Sebela Pharmaceuticals, Inc、Novartis AG、Pfizer Inc、Strides Pharma Science Limited、Tolmar Pharmaceuticals, Inc、Lupin Pharmaceuticals, Inc、Bausch Health、Sanofi、Atlantic Healthcare、AbbVie、Takeda Pharmaceutical Company Limited、Ironwood Pharmaceuticals、Alfasigma、Bayer、Astellas Pharma） ・結論 |
Pouchitis is an inflammatory disease which occurs in the lining of pouch developed during surgery to treat ulcerative colitis or other type of colitis disease. Many patients having ulcerative colitis need to have removed their diseased colon and bowel reconnect with the J pouch surgery procedure. Patients’ suffering from pouchitis shows the symptoms like abdominal pain, joint pain, cramps, fever, diarrhea, strong urge of bowel movement and fecal incontinence.
Market Analysis and Insights: Global Pouchitis Treatment Market
The global Pouchitis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pouchitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pouchitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pouchitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pouchitis Treatment market.
Global Pouchitis Treatment Scope and Market Size
Pouchitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pouchitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Treatment
Antibiotics
Probiotics
Others
By Route of Administration
Oral
Parenteral
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Tillotts Pharma AG
AstraZeneca
Teva Pharmaceutical Industries Ltd
Sebela Pharmaceuticals, Inc
Novartis AG
Pfizer Inc
Strides Pharma Science Limited
Tolmar Pharmaceuticals, Inc
Lupin Pharmaceuticals, Inc
Bausch Health
Sanofi
Atlantic Healthcare
AbbVie
Takeda Pharmaceutical Company Limited
Ironwood Pharmaceuticals
Alfasigma
Bayer
Astellas Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pouchitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Probiotics
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pouchitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pouchitis Treatment Market Perspective (2016-2027)
2.2 Pouchitis Treatment Growth Trends by Regions
2.2.1 Pouchitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pouchitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pouchitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pouchitis Treatment Industry Dynamic
2.3.1 Pouchitis Treatment Market Trends
2.3.2 Pouchitis Treatment Market Drivers
2.3.3 Pouchitis Treatment Market Challenges
2.3.4 Pouchitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pouchitis Treatment Players by Revenue
3.1.1 Global Top Pouchitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Pouchitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pouchitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pouchitis Treatment Revenue
3.4 Global Pouchitis Treatment Market Concentration Ratio
3.4.1 Global Pouchitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pouchitis Treatment Revenue in 2020
3.5 Pouchitis Treatment Key Players Head office and Area Served
3.6 Key Players Pouchitis Treatment Product Solution and Service
3.7 Date of Enter into Pouchitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pouchitis Treatment Breakdown Data by Type
4.1 Global Pouchitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pouchitis Treatment Forecasted Market Size by Type (2022-2027)
5 Pouchitis Treatment Breakdown Data by Application
5.1 Global Pouchitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pouchitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pouchitis Treatment Market Size (2016-2027)
6.2 North America Pouchitis Treatment Market Size by Type
6.2.1 North America Pouchitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Pouchitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Pouchitis Treatment Market Size by Type (2016-2027)
6.3 North America Pouchitis Treatment Market Size by Application
6.3.1 North America Pouchitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Pouchitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Pouchitis Treatment Market Size by Application (2016-2027)
6.4 North America Pouchitis Treatment Market Size by Country
6.4.1 North America Pouchitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Pouchitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pouchitis Treatment Market Size (2016-2027)
7.2 Europe Pouchitis Treatment Market Size by Type
7.2.1 Europe Pouchitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pouchitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pouchitis Treatment Market Size by Type (2016-2027)
7.3 Europe Pouchitis Treatment Market Size by Application
7.3.1 Europe Pouchitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pouchitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pouchitis Treatment Market Size by Application (2016-2027)
7.4 Europe Pouchitis Treatment Market Size by Country
7.4.1 Europe Pouchitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pouchitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pouchitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pouchitis Treatment Market Size by Type
8.2.1 Asia-Pacific Pouchitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pouchitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pouchitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pouchitis Treatment Market Size by Application
8.3.1 Asia-Pacific Pouchitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pouchitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pouchitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pouchitis Treatment Market Size by Region
8.4.1 Asia-Pacific Pouchitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pouchitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pouchitis Treatment Market Size (2016-2027)
9.2 Latin America Pouchitis Treatment Market Size by Type
9.2.1 Latin America Pouchitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pouchitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pouchitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Pouchitis Treatment Market Size by Application
9.3.1 Latin America Pouchitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pouchitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pouchitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Pouchitis Treatment Market Size by Country
9.4.1 Latin America Pouchitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pouchitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pouchitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pouchitis Treatment Market Size by Type
10.2.1 Middle East & Africa Pouchitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pouchitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pouchitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pouchitis Treatment Market Size by Application
10.3.1 Middle East & Africa Pouchitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pouchitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pouchitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pouchitis Treatment Market Size by Country
10.4.1 Middle East & Africa Pouchitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pouchitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Tillotts Pharma AG
11.1.1 Tillotts Pharma AG Company Details
11.1.2 Tillotts Pharma AG Business Overview
11.1.3 Tillotts Pharma AG Pouchitis Treatment Introduction
11.1.4 Tillotts Pharma AG Revenue in Pouchitis Treatment Business (2016-2021)
11.1.5 Tillotts Pharma AG Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Pouchitis Treatment Introduction
11.2.4 AstraZeneca Revenue in Pouchitis Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Teva Pharmaceutical Industries Ltd
11.3.1 Teva Pharmaceutical Industries Ltd Company Details
11.3.2 Teva Pharmaceutical Industries Ltd Business Overview
11.3.3 Teva Pharmaceutical Industries Ltd Pouchitis Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Ltd Revenue in Pouchitis Treatment Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Ltd Recent Development
11.4 Sebela Pharmaceuticals, Inc
11.4.1 Sebela Pharmaceuticals, Inc Company Details
11.4.2 Sebela Pharmaceuticals, Inc Business Overview
11.4.3 Sebela Pharmaceuticals, Inc Pouchitis Treatment Introduction
11.4.4 Sebela Pharmaceuticals, Inc Revenue in Pouchitis Treatment Business (2016-2021)
11.4.5 Sebela Pharmaceuticals, Inc Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Pouchitis Treatment Introduction
11.5.4 Novartis AG Revenue in Pouchitis Treatment Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Pouchitis Treatment Introduction
11.6.4 Pfizer Inc Revenue in Pouchitis Treatment Business (2016-2021)
11.6.5 Pfizer Inc Recent Development
11.7 Strides Pharma Science Limited
11.7.1 Strides Pharma Science Limited Company Details
11.7.2 Strides Pharma Science Limited Business Overview
11.7.3 Strides Pharma Science Limited Pouchitis Treatment Introduction
11.7.4 Strides Pharma Science Limited Revenue in Pouchitis Treatment Business (2016-2021)
11.7.5 Strides Pharma Science Limited Recent Development
11.8 Tolmar Pharmaceuticals, Inc
11.8.1 Tolmar Pharmaceuticals, Inc Company Details
11.8.2 Tolmar Pharmaceuticals, Inc Business Overview
11.8.3 Tolmar Pharmaceuticals, Inc Pouchitis Treatment Introduction
11.8.4 Tolmar Pharmaceuticals, Inc Revenue in Pouchitis Treatment Business (2016-2021)
11.8.5 Tolmar Pharmaceuticals, Inc Recent Development
11.9 Lupin Pharmaceuticals, Inc
11.9.1 Lupin Pharmaceuticals, Inc Company Details
11.9.2 Lupin Pharmaceuticals, Inc Business Overview
11.9.3 Lupin Pharmaceuticals, Inc Pouchitis Treatment Introduction
11.9.4 Lupin Pharmaceuticals, Inc Revenue in Pouchitis Treatment Business (2016-2021)
11.9.5 Lupin Pharmaceuticals, Inc Recent Development
11.10 Bausch Health
11.10.1 Bausch Health Company Details
11.10.2 Bausch Health Business Overview
11.10.3 Bausch Health Pouchitis Treatment Introduction
11.10.4 Bausch Health Revenue in Pouchitis Treatment Business (2016-2021)
11.10.5 Bausch Health Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Pouchitis Treatment Introduction
11.11.4 Sanofi Revenue in Pouchitis Treatment Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Atlantic Healthcare
11.12.1 Atlantic Healthcare Company Details
11.12.2 Atlantic Healthcare Business Overview
11.12.3 Atlantic Healthcare Pouchitis Treatment Introduction
11.12.4 Atlantic Healthcare Revenue in Pouchitis Treatment Business (2016-2021)
11.12.5 Atlantic Healthcare Recent Development
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Pouchitis Treatment Introduction
11.13.4 AbbVie Revenue in Pouchitis Treatment Business (2016-2021)
11.13.5 AbbVie Recent Development
11.14 Takeda Pharmaceutical Company Limited
11.14.1 Takeda Pharmaceutical Company Limited Company Details
11.14.2 Takeda Pharmaceutical Company Limited Business Overview
11.14.3 Takeda Pharmaceutical Company Limited Pouchitis Treatment Introduction
11.14.4 Takeda Pharmaceutical Company Limited Revenue in Pouchitis Treatment Business (2016-2021)
11.14.5 Takeda Pharmaceutical Company Limited Recent Development
11.15 Ironwood Pharmaceuticals
11.15.1 Ironwood Pharmaceuticals Company Details
11.15.2 Ironwood Pharmaceuticals Business Overview
11.15.3 Ironwood Pharmaceuticals Pouchitis Treatment Introduction
11.15.4 Ironwood Pharmaceuticals Revenue in Pouchitis Treatment Business (2016-2021)
11.15.5 Ironwood Pharmaceuticals Recent Development
11.16 Alfasigma
11.16.1 Alfasigma Company Details
11.16.2 Alfasigma Business Overview
11.16.3 Alfasigma Pouchitis Treatment Introduction
11.16.4 Alfasigma Revenue in Pouchitis Treatment Business (2016-2021)
11.16.5 Alfasigma Recent Development
11.17 Bayer
11.17.1 Bayer Company Details
11.17.2 Bayer Business Overview
11.17.3 Bayer Pouchitis Treatment Introduction
11.17.4 Bayer Revenue in Pouchitis Treatment Business (2016-2021)
11.17.5 Bayer Recent Development
11.18 Astellas Pharma
11.18.1 Astellas Pharma Company Details
11.18.2 Astellas Pharma Business Overview
11.18.3 Astellas Pharma Pouchitis Treatment Introduction
11.18.4 Astellas Pharma Revenue in Pouchitis Treatment Business (2016-2021)
11.18.5 Astellas Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pouchitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Probiotics
Table 4. Key Players of Others
Table 5. Global Pouchitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pouchitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pouchitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pouchitis Treatment Market Share by Regions (2016-2021)
Table 9. Global Pouchitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pouchitis Treatment Market Share by Regions (2022-2027)
Table 11. Pouchitis Treatment Market Trends
Table 12. Pouchitis Treatment Market Drivers
Table 13. Pouchitis Treatment Market Challenges
Table 14. Pouchitis Treatment Market Restraints
Table 15. Global Pouchitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pouchitis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Pouchitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pouchitis Treatment as of 2020)
Table 18. Ranking of Global Top Pouchitis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pouchitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pouchitis Treatment Product Solution and Service
Table 22. Date of Enter into Pouchitis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pouchitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pouchitis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Pouchitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pouchitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pouchitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pouchitis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Pouchitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pouchitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pouchitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pouchitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pouchitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pouchitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pouchitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pouchitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pouchitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pouchitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pouchitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pouchitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pouchitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pouchitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pouchitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pouchitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pouchitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pouchitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pouchitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pouchitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pouchitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pouchitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pouchitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pouchitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pouchitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pouchitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pouchitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pouchitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pouchitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pouchitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pouchitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pouchitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Tillotts Pharma AG Company Details
Table 63. Tillotts Pharma AG Business Overview
Table 64. Tillotts Pharma AG Pouchitis Treatment Product
Table 65. Tillotts Pharma AG Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 66. Tillotts Pharma AG Recent Development
Table 67. AstraZeneca Company Details
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Pouchitis Treatment Product
Table 70. AstraZeneca Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Teva Pharmaceutical Industries Ltd Company Details
Table 73. Teva Pharmaceutical Industries Ltd Business Overview
Table 74. Teva Pharmaceutical Industries Ltd Pouchitis Treatment Product
Table 75. Teva Pharmaceutical Industries Ltd Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 76. Teva Pharmaceutical Industries Ltd Recent Development
Table 77. Sebela Pharmaceuticals, Inc Company Details
Table 78. Sebela Pharmaceuticals, Inc Business Overview
Table 79. Sebela Pharmaceuticals, Inc Pouchitis Treatment Product
Table 80. Sebela Pharmaceuticals, Inc Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 81. Sebela Pharmaceuticals, Inc Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Pouchitis Treatment Product
Table 85. Novartis AG Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Pfizer Inc Company Details
Table 88. Pfizer Inc Business Overview
Table 89. Pfizer Inc Pouchitis Treatment Product
Table 90. Pfizer Inc Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 91. Pfizer Inc Recent Development
Table 92. Strides Pharma Science Limited Company Details
Table 93. Strides Pharma Science Limited Business Overview
Table 94. Strides Pharma Science Limited Pouchitis Treatment Product
Table 95. Strides Pharma Science Limited Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 96. Strides Pharma Science Limited Recent Development
Table 97. Tolmar Pharmaceuticals, Inc Company Details
Table 98. Tolmar Pharmaceuticals, Inc Business Overview
Table 99. Tolmar Pharmaceuticals, Inc Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 100. Tolmar Pharmaceuticals, Inc Recent Development
Table 101. Lupin Pharmaceuticals, Inc Company Details
Table 102. Lupin Pharmaceuticals, Inc Business Overview
Table 103. Lupin Pharmaceuticals, Inc Pouchitis Treatment Product
Table 104. Lupin Pharmaceuticals, Inc Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 105. Lupin Pharmaceuticals, Inc Recent Development
Table 106. Bausch Health Company Details
Table 107. Bausch Health Business Overview
Table 108. Bausch Health Pouchitis Treatment Product
Table 109. Bausch Health Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 110. Bausch Health Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Pouchitis Treatment Product
Table 114. Sanofi Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. Atlantic Healthcare Company Details
Table 117. Atlantic Healthcare Business Overview
Table 118. Atlantic Healthcare Pouchitis Treatment Product
Table 119. Atlantic Healthcare Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 120. Atlantic Healthcare Recent Development
Table 121. AbbVie Company Details
Table 122. AbbVie Business Overview
Table 123. AbbVie Pouchitis Treatment Product
Table 124. AbbVie Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 125. AbbVie Recent Development
Table 126. Takeda Pharmaceutical Company Limited Company Details
Table 127. Takeda Pharmaceutical Company Limited Business Overview
Table 128. Takeda Pharmaceutical Company Limited Pouchitis Treatment Product
Table 129. Takeda Pharmaceutical Company Limited Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 130. Takeda Pharmaceutical Company Limited Recent Development
Table 131. Ironwood Pharmaceuticals Company Details
Table 132. Ironwood Pharmaceuticals Business Overview
Table 133. Ironwood Pharmaceuticals Pouchitis Treatment Product
Table 134. Ironwood Pharmaceuticals Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 135. Ironwood Pharmaceuticals Recent Development
Table 136. Alfasigma Company Details
Table 137. Alfasigma Business Overview
Table 138. Alfasigma Pouchitis Treatment Product
Table 139. Alfasigma Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 140. Alfasigma Recent Development
Table 141. Bayer Company Details
Table 142. Bayer Business Overview
Table 143. Bayer Pouchitis Treatment Product
Table 144. Bayer Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 145. Bayer Recent Development
Table 146. Astellas Pharma Company Details
Table 147. Astellas Pharma Business Overview
Table 148. Astellas Pharma Pouchitis Treatment Product
Table 149. Astellas Pharma Revenue in Pouchitis Treatment Business (2016-2021) & (US$ Million)
Table 150. Astellas Pharma Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pouchitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Probiotics Features
Figure 4. Others Features
Figure 5. Global Pouchitis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Pouchitis Treatment Report Years Considered
Figure 10. Global Pouchitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pouchitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pouchitis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Pouchitis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Pouchitis Treatment Market Share by Players in 2020
Figure 15. Global Top Pouchitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pouchitis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pouchitis Treatment Revenue in 2020
Figure 17. Global Pouchitis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Pouchitis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pouchitis Treatment Market Share by Type (2016-2027)
Figure 21. North America Pouchitis Treatment Market Share by Application (2016-2027)
Figure 22. North America Pouchitis Treatment Market Share by Country (2016-2027)
Figure 23. United States Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pouchitis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Pouchitis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Pouchitis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pouchitis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pouchitis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pouchitis Treatment Market Share by Region (2016-2027)
Figure 39. China Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pouchitis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Pouchitis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Pouchitis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pouchitis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pouchitis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pouchitis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pouchitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Tillotts Pharma AG Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 60. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 61. Sebela Pharmaceuticals, Inc Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 63. Pfizer Inc Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 64. Strides Pharma Science Limited Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 65. Tolmar Pharmaceuticals, Inc Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 66. Lupin Pharmaceuticals, Inc Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 67. Bausch Health Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 69. Atlantic Healthcare Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 70. AbbVie Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 71. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 72. Ironwood Pharmaceuticals Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 73. Alfasigma Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 74. Bayer Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 75. Astellas Pharma Revenue Growth Rate in Pouchitis Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の色汗症治療市場規模・現状・予測（2021年-2027年） Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless…- 世界の扁桃周囲膿瘍治療市場規模・現状・予測（2021年-2027年） Peritonsillar abscess (PTA) also called quinsy. In this condition, the infection spreads behind tonsillitis. It occurs when there is pus collection and the infection spreads beyond the tonsils into the neck and chest. These swollen tissues cause airway blockage. Diagnosis can be done clinically, by …
- 世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Von Willebrand Disease Treatment Market The global Von Willebrand Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界の咽後膿瘍治療市場規模・現状・予測（2021年-2027年） A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess…
- 世界の多汗症治療市場規模・現状・予測（2021年-2027年） Hyperhidrosis is a condition characterized by abnormally increased sweating, in excess of that required for regulation of body temperature. Although primarily a physical burden, hyperhidrosis can deteriorate quality of life from a psychological, emotional, and social perspective. It has been called …